If You Don’t Know Jak, You Will Now: Overview And Update In Psoriasis
Day One: Friday, September 30, 2022 | 1:00 PM - 1:30 PM MT:
Provide an overview of the normal function of the JAK-STAT signaling pathway within cells. We will also discuss the research and clinical efforts that led to the development of small molecules that inhibit this intracellular pathway, known as JAK inhibitors, and their potential therapeutic role for chronic inflammatory conditions such as psoriasis and atopic dermatitis. Finally, we will compare and contrast this novel class of medications to current FDA-approved therapies in psoriasis (e.g., efficacy, onset of action, overall safety, and common adverse events).Speaker
Psoriasis Panel
Day One: Friday, September 30, 2022 | 1:30 PM - 2:30 PM
Psoriasis is a complex disease and management is not a linear process. To understand how different aspects of disease management come together into a harmonious and coherent treatment regimen, an interdisciplinary panel will discuss the various aspects of disease management. Using a case-based discussion, the panel will review the various aspects of treatment.Speaker